Modelling and analysis of an HIV model with control strategies and cost-effectiveness

被引:3
|
作者
Chazuka, Zviiteyi [1 ]
Madubueze, Chinwendu E. [2 ]
Mathebula, Dephney [1 ]
机构
[1] Univ South Africa, Coll Econ & Management Sci, Dept Decis Sci, Preller St, Pretoria, South Africa
[2] Joseph Sarwuan Tarka Univ, Dept Math, Makurdi, Nigeria
来源
RESULTS IN CONTROL AND OPTIMIZATION | 2024年 / 14卷
关键词
Pre-exposure prophylaxis; Adherence; Optimal control; Pontryagin's maximum principle; Cost-effectiveness; DISEASE;
D O I
10.1016/j.rico.2023.100355
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
The Human Immunodeficiency Virus (HIV) remains a significant public health concern, despite global efforts to reduce new infections and increase access to antiretroviral treatment. While pre-exposure prophylaxis (PrEP) has shown promise in reducing new infections, its overall effectiveness is hindered by challenges in adherence. In this paper, a novel model was proposed. The basic properties of the model were established and the reproduction number for the model without control was computed. We conducted a sensitivity analysis to highlight the need for optimal control analysis and hence proposed an optimal control model that incorporates PrEP, condom use, and antiretroviral treatment to capture the dynamics of HIV transmission. The existence of the optimal control was mathematically proven and Pontryagin's maximum principle was employed to establish the necessary optimal control conditions. Utilizing demographic and epidemiological parameters specific to South Africa, we conducted numerical simulations. The results demonstrate the community-level benefits of implementing a combination of control measures for HIV reduction. Additionally, a cost-effectiveness analysis was performed to determine the most effective and economically viable control strategies. We anticipate that the findings from this analysis will provide valuable insights for policymakers in designing effective HIV control programmes.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study
    Lidia Kardaś-Słoma
    Sandra Fournier
    Jean-Claude Dupont
    Lise Rochaix
    Gabriel Birgand
    Jean-Ralph Zahar
    François-Xavier Lescure
    Solen Kernéis
    Isabelle Durand-Zaleski
    Jean-Christophe Lucet
    Antimicrobial Resistance & Infection Control, 11
  • [42] Effective strategies toward controlling tuberculosis: optimal control and cost-effectiveness analysis
    Khoda, Pooja
    Bajiya, Vijay Pal
    Prasad, Sada Nand
    EUROPEAN PHYSICAL JOURNAL PLUS, 2025, 140 (01):
  • [43] Cost-effectiveness of strategies to control the spread of carbapenemase-producing Enterobacterales in hospitals: a modelling study
    Kardas-Sloma, Lidia
    Fournier, Sandra
    Dupont, Jean-Claude
    Rochaix, Lise
    Birgand, Gabriel
    Zahar, Jean-Ralph
    Lescure, Francois-Xavier
    Kerneis, Solen
    Durand-Zaleski, Isabelle
    Lucet, Jean-Christophe
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2022, 11 (01)
  • [44] Modelling cost-effectiveness in osteoporosis
    Kanis, John A.
    Adams, Judith
    Borgstrom, Fred
    Cooper, Cyrus
    Jonsson, Bengt
    Preedy, Danielle
    Selby, Peter
    Compston, Juliet
    BONE, 2008, 43 (01) : 215 - 216
  • [45] Cost-effectiveness analysis of optimal control strategies on the transmission dynamics of HIV and Varicella-Zoster co-infection
    Kotola, Belela Samuel
    Teklu, Shewafera Wondimagegnhu
    SCIENTIFIC AFRICAN, 2024, 25
  • [46] AIR POLLUTION CONTROL COST-EFFECTIVENESS MODEL
    JIMESON, RM
    AACE BULLETIN, 1971, 13 (03): : 7 - &
  • [47] Cost-Effectiveness Analysis and Decision Modelling: A Tutorial for Clinicians
    Gupta, Nidhi
    Verma, Rohan
    Dhiman, Radha K.
    Rajsekhar, Kavitha
    Prinja, Shankar
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) : 177 - 184
  • [48] MODELLING UNCERTAIN FUTURE EVENTS IN COST-EFFECTIVENESS ANALYSIS
    Mahon, R.
    VALUE IN HEALTH, 2013, 16 (07) : A592 - A592
  • [49] Optimal control and cost-effectiveness analysis of a Huanglongbing model with comprehensive interventions
    Zhang, Fumin
    Qiu, Zhipeng
    Huang, Aijun
    Zhao, Xin
    APPLIED MATHEMATICAL MODELLING, 2021, 90 : 719 - 741
  • [50] EPICE-HIV: An Epidemiologic Cost-Effectiveness Model for HIV Treatment
    Vandewalle, Bjoern
    Llibre, Josep M.
    Parienti, Jean-Jacques
    Ustianowski, Andrew
    Camacho, Ricardo
    Smith, Colette
    Miners, Alec
    Ferreira, Diana
    Felix, Jorge
    PLOS ONE, 2016, 11 (02):